|
|
|
|
|
Irinotecan Hydrochloride,GMP and USDMF |
|
100286-90-6 |
|
100286-90-6 |
|
Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. |
|
Assay:NLT98% |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|